HEALTHEQUITY INC (HQY) — insider trading
Health Care · NASDAQ
HEALTHEQUITY INC (HQY) has 32 reported SEC Form 4 insider transactions in our data, including 7 open-market sales among the most recent 32 (latest 2026-10-06).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Ladd Delano | Officer (EVP, General Counsel) | Shares withheld for taxes / exercise cost | 1,080 | $91.16 | $98.4K | Form 4 |
| 2026-10-06 | Lucania James M | Officer (EVP & CFO) | Shares withheld for taxes / exercise cost | 2,822 | $91.16 | $257.2K | Form 4 |
| 2026-10-06 | Neeleman Stephen | Director, Officer (FOUNDER AND VICE CHAIRMAN) | Shares withheld for taxes / exercise cost | 1,095 | $91.16 | $99.8K | Form 4 |
| 2026-10-06 | Gathright Michael | Officer (Chief Customer Officer) | Shares withheld for taxes / exercise cost | 662 | $91.16 | $60.3K | Form 4 |
| 2026-10-06 | Fiore Michael Henry | Other | Shares withheld for taxes / exercise cost | 2,032 | $91.16 | $185.2K | Form 4 |
| 2026-10-06 | Cutler Scott | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 1,230 | $91.16 | $112.1K | Form 4 |
| 2026-09-17 | Neeleman Stephen | Director, Officer (FOUNDER AND VICE CHAIRMAN) | Bona fide gift | 1,500 | — | $0 | Form 4 |
| 2026-08-25 | DILLON ADRIAN T | Director | Option exercise / conversion (derivative) | 7,632 | — | $0 | Form 4 |
| 2026-08-25 | DILLON ADRIAN T | Director | Open-market sale | 1,332 | $105.26 | $140.2K | Form 4 |
| 2026-08-25 | DILLON ADRIAN T | Director | Open-market sale | 6,300 | $104.47 | $658.2K | Form 4 |
| 2026-08-25 | DILLON ADRIAN T | Director | Option exercise / conversion | 7,632 | $32.50 | $248.0K | Form 4 |
| 2026-07-10 | Fiore Michael Henry | Officer (EVP, CHIEF COMMERCIAL OFFICER) | Open-market sale | 2,354 | $95.00 | $223.6K | Form 4 |
| 2026-07-09 | Gathright Michael | Officer (Chief Customer Officer) | Shares withheld for taxes / exercise cost | 2,270 | $93.07 | $211.3K | Form 4 |
| 2026-07-08 | Fiore Michael Henry | Officer (EVP, CHIEF COMMERCIAL OFFICER) | Shares withheld for taxes / exercise cost | 2,045 | $95.08 | $194.4K | Form 4 |
| 2026-07-08 | Cutler Scott | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 1,238 | $95.08 | $117.7K | Form 4 |
| 2026-07-08 | Ladd Delano | Officer (EVP, General Counsel) | Shares withheld for taxes / exercise cost | 1,087 | $95.08 | $103.4K | Form 4 |
| 2026-07-08 | Lucania James M | Officer (EVP & CFO) | Shares withheld for taxes / exercise cost | 2,839 | $95.08 | $269.9K | Form 4 |
| 2026-07-08 | Neeleman Stephen | Director, Officer (FOUNDER AND VICE CHAIRMAN) | Shares withheld for taxes / exercise cost | 1,103 | $95.08 | $104.9K | Form 4 |
| 2026-07-02 | Fiore Michael Henry | Officer (EVP, CHIEF COMMERCIAL OFFICER) | Open-market sale | 2,470 | $95.00 | $234.7K | Form 4 |
| 2026-06-25 | SELANDER ROBERT W | Director | Grant / award / vesting | 2,877 | — | $0 | Form 4 |
| 2026-06-25 | Dilsaver Evelyn S | Director | Grant / award / vesting | 2,877 | — | $0 | Form 4 |
| 2026-06-25 | DILLON ADRIAN T | Director | Grant / award / vesting | 2,877 | — | $0 | Form 4 |
| 2026-06-25 | Wellborn Gayle Furgurson | Director | Grant / award / vesting | 2,877 | — | $0 | Form 4 |
| 2026-06-25 | Parker Stuart B. | Director | Grant / award / vesting | 2,877 | — | $0 | Form 4 |
| 2026-06-25 | McCowan Debra Charlotte | Director | Grant / award / vesting | 2,877 | — | $0 | Form 4 |
| 2026-06-25 | Natarajan Rajesh | Director | Grant / award / vesting | 2,877 | — | $0 | Form 4 |
| 2026-06-25 | Gassen William | Director | Grant / award / vesting | 2,877 | — | $0 | Form 4 |
| 2026-05-29 | Fiore Michael Henry | Officer (EVP, CHIEF COMMERCIAL OFFICER) | Open-market sale | 3,142 | $95.00 | $298.5K | Form 4 |
| 2026-05-28 | Ladd Delano | Officer (EVP, General Counsel) | Open-market sale | 7,500 | $90.00 | $675.0K | Form 4 |
| 2026-05-28 | Wellborn Gayle Furgurson | Director | Option exercise / conversion (derivative) | 2,439 | — | $0 | Form 4 |
| 2026-05-28 | Wellborn Gayle Furgurson | Director | Open-market sale | 2,439 | $90.00 | $219.5K | Form 4 |
| 2026-05-28 | Wellborn Gayle Furgurson | Director | Option exercise / conversion | 2,439 | $47.21 | $115.1K | Form 4 |
Ask the chat about HQY's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: HEALTHEQUITY INC (HQY).
Last updated 2026-10-06 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.